标题
Overview of gene therapy in spinal muscular atrophy and Duchenne muscular dystrophy
作者
关键词
-
出版物
PEDIATRIC PULMONOLOGY
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2020-09-05
DOI
10.1002/ppul.25055
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Immune Responses to Viral Gene Therapy Vectors
- (2020) Jamie L. Shirley et al. MOLECULAR THERAPY
- Increased dystrophin production with golodirsen in patients with Duchenne muscular dystrophy
- (2020) Diane E. Frank et al. NEUROLOGY
- The 10th Oligonucleotide Therapy Approved: Golodirsen for Duchenne Muscular Dystrophy
- (2020) Annemieke Aartsma-Rus et al. Nucleic Acid Therapeutics
- Safety and effectiveness of ataluren: comparison of results from the STRIDE Registry and CINRG DMD Natural History Study
- (2020) Eugenio Mercuri et al. Journal of Comparative Effectiveness Research
- Successful Transduction with AAV Vectors after Selective Depletion of Anti-AAV Antibodies by Immunoadsorption
- (2020) Alejandro Orlowski et al. Molecular Therapy-Methods & Clinical Development
- Onasemnogene Abeparvovec-xioi: Gene Therapy for Spinal Muscular Atrophy
- (2020) Debra Stevens et al. ANNALS OF PHARMACOTHERAPY
- Common therapeutic advances for Duchenne muscular dystrophy (DMD)
- (2020) Arash Salmaninejad et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- Safety, Tolerability, and Efficacy of Viltolarsen in Boys With Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping
- (2020) Paula R. Clemens et al. JAMA Neurology
- Assessment of Systemic Delivery of rAAVrh74.MHCK7.micro-dystrophin in Children With Duchenne Muscular Dystrophy
- (2020) Jerry R. Mendell et al. JAMA Neurology
- Gene Therapy for Spinal Muscular Atrophy: Safety and Early Outcomes
- (2020) Megan A. Waldrop et al. PEDIATRICS
- rAAVrh74.MCK.GALGT2 Protects Against Loss of Hemodynamic Function in the Aging mdx Mouse Heart
- (2019) Rui Xu et al. MOLECULAR THERAPY
- Twice-weekly glucocorticosteroids in infants and young boys with Duchenne muscular dystrophy
- (2019) Anne M. Connolly et al. MUSCLE & NERVE
- Current Treatment Options in Neurology—SMA Therapeutics
- (2019) Megan A. Waldrop et al. Current Treatment Options in Neurology
- Impact of age and motor function in a phase 1/2A study of infants with SMA Type 1 receiving single-dose gene replacement therapy
- (2019) Linda P. Lowes et al. PEDIATRIC NEUROLOGY
- Boys with a rare muscle disease are breathing on their own, thanks to gene therapy
- (2019) Jocelyn Kaiser SCIENCE
- Update in Duchenne and Becker muscular dystrophy
- (2019) Megan A. Waldrop et al. CURRENT OPINION IN NEUROLOGY
- Scoliosis and spinal muscular atrophy in the new world of medical therapy
- (2019) Luca Labianca et al. JOURNAL OF PEDIATRIC ORTHOPAEDICS-PART B
- Gene Therapy
- (2019) Katherine A. High et al. NEW ENGLAND JOURNAL OF MEDICINE
- From Clinical Trials to Clinical Practice: Practical Considerations for Gene Replacement Therapy in SMA Type 1
- (2019) Samiah A. Al-Zaidy et al. PEDIATRIC NEUROLOGY
- Vamorolone trial in Duchenne muscular dystrophy shows dose-related improvement of muscle function
- (2019) Eric P. Hoffman et al. NEUROLOGY
- Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE study
- (2019) Darryl C. De Vivo et al. NEUROMUSCULAR DISORDERS
- Non-immunogenic utrophin gene therapy for the treatment of muscular dystrophy animal models
- (2019) Yafeng Song et al. NATURE MEDICINE
- P.353FIREFISH Part 1: 16-month safety and exploratory outcomes of risdiplam (RG7916) treatment in infants with type 1 spinal muscular atrophy
- (2019) G. Baranello et al. NEUROMUSCULAR DISORDERS
- O.41Sunfish part 1: 18-month safety and exploratory outcomes of risdiplam (RG7916) treatment in patients with type 2 or 3 spinal muscular atrophy
- (2019) E. Mercuri et al. NEUROMUSCULAR DISORDERS
- Diagnosis and management of Duchenne muscular dystrophy, part 3: primary care, emergency management, psychosocial care, and transitions of care across the lifespan
- (2018) David J Birnkrant et al. LANCET NEUROLOGY
- Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management
- (2018) David J Birnkrant et al. LANCET NEUROLOGY
- Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management
- (2018) David J Birnkrant et al. LANCET NEUROLOGY
- Systemic AAV micro-dystrophin gene therapy for Duchenne muscular dystrophy
- (2018) Dongsheng Duan MOLECULAR THERAPY
- Eteplirsen treatment for Duchenne muscular dystrophy
- (2018) Jay S. Charleston et al. NEUROLOGY
- Diagnosis and management of spinal muscular atrophy: Part 2: Pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethics
- (2018) Richard S. Finkel et al. NEUROMUSCULAR DISORDERS
- Correlation between SMA type and SMN2 copy number revisited: An analysis of 625 unrelated Spanish patients and a compilation of 2834 reported cases
- (2018) Maite Calucho et al. NEUROMUSCULAR DISORDERS
- Diagnosis and management of spinal muscular atrophy: Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care
- (2018) Eugenio Mercuri et al. NEUROMUSCULAR DISORDERS
- Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy
- (2018) Eugenio Mercuri et al. NEW ENGLAND JOURNAL OF MEDICINE
- Discovery of Risdiplam, a Selective Survival of Motor Neuron-2 (SMN2) Gene Splicing Modifier for the Treatment of Spinal Muscular Atrophy (SMA)
- (2018) Hasane Ratni et al. JOURNAL OF MEDICINAL CHEMISTRY
- Gene editing restores dystrophin expression in a canine model of Duchenne muscular dystrophy
- (2018) Leonela Amoasii et al. SCIENCE
- A phase 1 healthy male volunteer single escalating dose study of the pharmacokinetics and pharmacodynamics of risdiplam (RG7916, RO7034067), a SMN2 splicing modifier
- (2018) Stefan Sturm et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Health outcomes in spinal muscular atrophy type 1 following AVXS‐101 gene replacement therapy
- (2018) Samiah Al‐Zaidy et al. PEDIATRIC PULMONOLOGY
- Secondary Conditions Among Males With Duchenne or Becker Muscular Dystrophy
- (2017) Rebecca Latimer et al. JOURNAL OF CHILD NEUROLOGY
- Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Craig M McDonald et al. LANCET
- Progress toward Gene Therapy for Duchenne Muscular Dystrophy
- (2017) Joel R. Chamberlain et al. MOLECULAR THERAPY
- Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy
- (2017) Jerry R. Mendell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy
- (2017) Richard S. Finkel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Binding to SMN2 pre-mRNA-protein complex elicits specificity for small molecule splicing modifiers
- (2017) Manaswini Sivaramakrishnan et al. Nature Communications
- Longitudinal effect of eteplirsen versus historical control on ambulation in Duchenne muscular dystrophy
- (2016) Jerry R. Mendell et al. ANNALS OF NEUROLOGY
- Quantifying the burden of caregiving in Duchenne muscular dystrophy
- (2016) Erik Landfeldt et al. JOURNAL OF NEUROLOGY
- Practice guideline update summary: Corticosteroid treatment of Duchenne muscular dystrophy
- (2016) David Gloss et al. NEUROLOGY
- Results from a phase 1 study of nusinersen (ISIS-SMNRx) in children with spinal muscular atrophy
- (2016) Claudia A. Chiriboga et al. NEUROLOGY
- Prevalence of Fatigue, Pain, and Affective Disorders in Adults With Duchenne Muscular Dystrophy and Their Associations With Quality of Life
- (2015) Robert F. Pangalila et al. ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION
- Neurodevelopmental, emotional, and behavioural problems in Duchenne muscular dystrophy in relation to underlying dystrophin gene mutations
- (2015) Valeria Ricotti et al. DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY
- The TREAT-NMD DMD Global Database: Analysis of More than 7,000 Duchenne Muscular Dystrophy Mutations
- (2015) Catherine L. Bladen et al. HUMAN MUTATION
- Ataluren treatment of patients with nonsense mutation dystrophinopathy
- (2014) Katharine Bushby et al. MUSCLE & NERVE
- Observational study of spinal muscular atrophy type I and implications for clinical trials
- (2014) R. S. Finkel et al. NEUROLOGY
- Gene Therapy Prolongs Survival and Restores Function in Murine and Canine Models of Myotubular Myopathy
- (2014) M. K. Childers et al. Science Translational Medicine
- Eteplirsen for the treatment of Duchenne muscular dystrophy
- (2013) Jerry R. Mendell et al. ANNALS OF NEUROLOGY
- 2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
- (2013) Lorry G. Rubin et al. CLINICAL INFECTIOUS DISEASES
- Newborn bloodspot screening for Duchenne Muscular Dystrophy: 21 years experience in Wales (UK)
- (2013) Stuart J Moat et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Vascular Delivery of rAAVrh74.MCK.GALGT2 to the Gastrocnemius Muscle of the Rhesus Macaque Stimulates the Expression of Dystrophin and Laminin α2 Surrogates
- (2013) Louis G. Chicoine et al. MOLECULAR THERAPY
- Plasmapheresis Eliminates the Negative Impact of AAV Antibodies on Microdystrophin Gene Expression Following Vascular Delivery
- (2013) LG Chicoine et al. MOLECULAR THERAPY
- Evidence-based path to newborn screening for duchenne muscular dystrophy
- (2012) Jerry R. Mendell et al. ANNALS OF NEUROLOGY
- Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study
- (2011) Sebahattin Cirak et al. LANCET
- Non-5q spinal muscular atrophies: The alphanumeric soup thickens
- (2011) B. T. Darras NEUROLOGY
- Randomized, blinded trial of weekend vs daily prednisone in Duchenne muscular dystrophy
- (2011) D. M. Escolar et al. NEUROLOGY
- Prevalence of Serum IgG and Neutralizing Factors Against Adeno-Associated Virus (AAV) Types 1, 2, 5, 6, 8, and 9 in the Healthy Population: Implications for Gene Therapy Using AAV Vectors
- (2010) Sylvie Boutin et al. HUMAN GENE THERAPY
- Mutation spectrum of the dystrophin gene in 442 Duchenne/Becker muscular dystrophy cases from one Japanese referral center
- (2010) Yasuhiro Takeshima et al. JOURNAL OF HUMAN GENETICS
- Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN
- (2010) Kevin D Foust et al. NATURE BIOTECHNOLOGY
- Clinical and genetic characterization of manifesting carriers of DMD mutations
- (2010) Payam Soltanzadeh et al. NEUROMUSCULAR DISORDERS
- Dystrophin Immunity in Duchenne's Muscular Dystrophy
- (2010) Jerry R. Mendell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Systemic Delivery of scAAV9 Expressing SMN Prolongs Survival in a Model of Spinal Muscular Atrophy
- (2010) C. F. Valori et al. Science Translational Medicine
- Mutational spectrum of DMD mutations in dystrophinopathy patients: application of modern diagnostic techniques to a large cohort
- (2009) Kevin M. Flanigan et al. HUMAN MUTATION
- Theoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutations
- (2009) Annemieke Aartsma-Rus et al. HUMAN MUTATION
- Delayed Diagnosis in Duchenne Muscular Dystrophy: Data from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet)
- (2009) Emma Ciafaloni et al. JOURNAL OF PEDIATRICS
- The neonatal blood-brain barrier is functionally effective and immaturity does not explain differential targeting of AAV9
- (2009) Norman R Saunders et al. NATURE BIOTECHNOLOGY
- Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients
- (2008) Steven J. Howe et al. JOURNAL OF CLINICAL INVESTIGATION
- Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes
- (2008) Kevin D Foust et al. NATURE BIOTECHNOLOGY
- DMDpseudoexon mutations: splicing efficiency, phenotype, and potential therapy
- (2007) Olga L. Gurvich et al. ANNALS OF NEUROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now